---
schema_version: "secwatch.filing_event.v1"
accession: "0001681622-24-000068"
form_type: "8-K"
ticker: "VREX"
cik: "0001681622"
company_name: "Varex Imaging Corp"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:51:48.647535+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Varex Q3 FY2024 revenue down 10% YoY; Q4 guidance weak

## Summary
- Revenue $209M (-10% YoY); GAAP EPS $0.03, Non-GAAP EPS $0.14 vs $0.37 YoY.
- Medical segment revenue $149M (-15% YoY); Industrial segment $60M (+6% YoY).
- Cash flow from operations $8M; cash and equivalents $192M (flat vs FY2023).
- Q4 FY2024 guidance: revenue $190-210M, Non-GAAP EPS $0.00-$0.15, citing challenging market conditions.

## SEC filing metadata
- accession: 0001681622-24-000068
- form_type: 8-K
- ticker: VREX
- cik: 0001681622
- company_name: Varex Imaging Corp
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681622/000168162224000068/0001681622-24-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681622/000168162224000068/vrex-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001681622-24-000068
- JSON: https://secwatch.observer/filing/0001681622-24-000068.json
- Plain text: https://secwatch.observer/filing/0001681622-24-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.